Mercury Biopharmaceutical Corporation

Merdury Biopharmaceutical Corporation develops drugs for unmet medical needs in Taiwan. It develops the StackDose platform, a drug development technology that integrates formulation, 3D powder printing, and hardware and software to create drug-specific 3D printing production equipment. This platform can support hosted services and in-house product development for pharmaceutical companies. The company also offers formulation design and 3D pharmaceutical processing services. Founded in 2019, it is headquartered in New Taipei City, Taiwan.